Biomea Fusion Statistics
Total Valuation
Biomea Fusion has a market cap or net worth of $96.86 million. The enterprise value is $57.10 million.
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomea Fusion has 70.70 million shares outstanding. The number of shares has increased by 20.63% in one year.
| Current Share Class | 70.70M |
| Shares Outstanding | 70.70M |
| Shares Change (YoY) | +20.63% |
| Shares Change (QoQ) | +47.30% |
| Owned by Insiders (%) | 6.61% |
| Owned by Institutions (%) | 32.24% |
| Float | 62.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.22 |
| P/TBV Ratio | 6.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.18, with a Debt / Equity ratio of 0.44.
| Current Ratio | 3.18 |
| Quick Ratio | 3.00 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -209.00% and return on invested capital (ROIC) is -115.31%.
| Return on Equity (ROE) | -209.00% |
| Return on Assets (ROA) | -75.23% |
| Return on Invested Capital (ROIC) | -115.31% |
| Return on Capital Employed (ROCE) | -251.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$902,934 |
| Employee Count | 106 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.57% in the last 52 weeks. The beta is -0.18, so Biomea Fusion's price volatility has been lower than the market average.
| Beta (5Y) | -0.18 |
| 52-Week Price Change | -84.57% |
| 50-Day Moving Average | 1.77 |
| 200-Day Moving Average | 2.15 |
| Relative Strength Index (RSI) | 41.51 |
| Average Volume (20 Days) | 1,667,691 |
Short Selling Information
The latest short interest is 8.65 million, so 12.24% of the outstanding shares have been sold short.
| Short Interest | 8.65M |
| Short Previous Month | 7.75M |
| Short % of Shares Out | 12.24% |
| Short % of Float | 13.91% |
| Short Ratio (days to cover) | 3.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -99.66M |
| Pretax Income | -95.71M |
| Net Income | -95.71M |
| EBITDA | -97.83M |
| EBIT | -99.66M |
| Earnings Per Share (EPS) | -$2.20 |
Full Income Statement Balance Sheet
The company has $46.64 million in cash and $6.88 million in debt, giving a net cash position of $39.77 million or $0.56 per share.
| Cash & Cash Equivalents | 46.64M |
| Total Debt | 6.88M |
| Net Cash | 39.77M |
| Net Cash Per Share | $0.56 |
| Equity (Book Value) | 15.62M |
| Book Value Per Share | 0.26 |
| Working Capital | 33.88M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$86.43 million and capital expenditures -$82,000, giving a free cash flow of -$86.52 million.
| Operating Cash Flow | -86.43M |
| Capital Expenditures | -82,000 |
| Free Cash Flow | -86.52M |
| FCF Per Share | -$1.22 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Biomea Fusion does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.63% |
| Shareholder Yield | -20.63% |
| Earnings Yield | -98.81% |
| FCF Yield | -89.32% |
Analyst Forecast
The average price target for Biomea Fusion is $8.86, which is 546.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.86 |
| Price Target Difference | 546.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -22.00% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |